Found 90 matching trials
Gliflozins and Cardiovascular Risk Factors in Type 2 Diabetes (GIOIA) N/A GIOIA represents a multicenter pragmatic prospective cohort study, aimed at...
Show More Learn More & Join Trial
Bioequivalence of a 2.5 mg Linagliptin / 500 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 500 mg Tablets Administered Together in Healthy Volunteers PHASE1 Study to demonstrate bioequivalence of a 2.5 mg linagliptin / 500 mg metfor...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial Design PHASE3 The objective of the randomised part of the study is to investigate the eff...
Show More Location
1218.46.11005 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 Diabetes PHASE3 Diabetes mellitus is a wide-spread disease accompanied by strongly increase...
Show More Location
Clinical Research Center, Dept of Nephrology and Hypertenison, University of Erlangen/Nürnberg
Learn More & Join Trial
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study N/A To perform an observational analysis to emulate a target trial (i.e., a hyp...
Show More Status
Active Not Recruiting
Location
Brigham and Women's Hospital
Learn More & Join Trial
Bioavailability of Combination Tablet BI 1356/Metformin Compared With Single BI 1356 and Metformin Administered Together to Healthy Male and Female Subjects PHASE1 The objective was to assess the relative bioavailability of a pilot scale l...
Show More Location
Multiple Locations
Learn More & Join Trial
BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 Diabetes PHASE3 The objective of the current study is to investigate the efficacy, safety a...
Show More Location
1218.18.54001 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes N/A The purpose of this study is to compare the risk of serious adverse events ...
Show More Location
Lady Davis Institute for Medical Research, Jewish General Hospital
Learn More & Join Trial
Effect of Linagliptin on Insulin Sensitivity and Pancreatic Beta Cell Function in Patients With Type 2 Diabetes Mellitus PHASE4 This study is planned to evaluate if linagliptin can improve insulin sensit...
Show More Location
Postgraduate Institute of Medical Education & Research
Learn More & Join Trial
A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study PHASE1 To Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, ...
Show More Location
Chung-Ang University Gwangmyeong Hospital
Learn More & Join Trial